The FDA was set to fully approve the Pfizer vaccine in the US by early September, according to a report. The Food and Drug Administration (FDA) was set to fully approve the Pfizer vaccine in the United States by early September, according to a report. On Tuesday, the New York Times reported that the US … Read more
Pfizer planned to seek US authorization for COVID-19 booster shot. Pfizer Inc planned to ask regulators in the United States to authorize a booster shot of its COVID-19 vaccine within the next month. On Thursday, the drugmaker’s top scientist said that based on evidence of greater risk of coronavirus reinfection six months after vaccination and … Read more
Children in the Philippines can be vaccinated with Pfizer vaccine by 2nd half of 2021, according to Galvez Vaccine czar Secretary Carlito Galvez Jr on Monday said that children in the Philippines can be vaccinated with Pfizer vaccine by 2nd half of 2021. Children may soon get inoculated in the second half of 2021 with … Read more
The Philippines and Pfizer signed a supply deal for 40 million COVID-19 vaccine doses. On Sunday, the government said that the Philippines and Pfizer signed a supply deal for 40 million Pfizer-BioNTech COVID-19 vaccine doses. The Philippines had sealed its biggest COVID-19 vaccine procurement yet this year after signing a supply agreement with Pfizer for … Read more
Pfizer was “close to secure” a deal with the US government to supply additional doses of the COVID-19 vaccine, according to a report. Pfizer was “close to secure” a deal with the US government to supply at least tens of millions of additional doses of the COVID-19 vaccine in 2021 in exchange for a government … Read more
Pfizer CEO Albert Bourla said that he’s confident that COVID-19 vaccine supply would exceed needs by the end of 2021. Albert Bourla, the chief executive officer (CEO) of Pfizer Inc, on Wednesday said that he’s confident that there would be more COVID-19 vaccine doses than required to fight the coronavirus pandemic by the end of … Read more
Pfizer had ended its clinical trials for COVID-19 vaccine with 95% efficacy. Pfizer Inc. on Wednesday said that the final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective Also, Pfizer said that it had the required two months of safety data and will apply for an emergency use authorization … Read more
